BRCA1 and ovarian carcinoma: Strikingly, in ovarian cancer with loss of BRCA1, miR-622 impaired the NHEJ pathway but rescued HR-mediated DSB repair via downregulation of the ku70/ku80 complex during the S phase by inducing resistance to PARPi [145].